Cellectis Faces Rival's 10th Genome Engineering IP Suit
Precision's complaint, which targets Paris-based Cellectis and two subsidiaries, centered on meganucleases — “DNA scissors” that can recognize a specific binding site and break the DNA at or near that site. Precision said it was the exclusive licensee of the patent-in-suit, which issued Tuesday.
Durham, N.C.-based Precision and Cellectis...
To view the full article, register now.